Trial intelligence / Profile preview

Local Bonviva treatment to improve cemented hip prosthesis fixation

2009-014414-98Phase 2Completed

Sponsor
Department of Orthopaedic Surgery, University Hospital Linköping
Start
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of ibandronic acid in hip osteoarthritis, sponsored by Department of Orthopaedic Surgery, University Hospital Linköping. Primary endpoint: Periprosthetic bone resorption and fixation stability. Started Sep 2009; status: completed.

02

Drugs

ibandronic acid
03

Conditions

hip osteoarthritis

Beyond the preview

Go deeper on 2009-014414-98.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014414-98.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call